
1. j med chem. 2017 mar 23;60(6):2411-2424. doi: 10.1021/acs.jmedchem.6b01766. epub 
2017 mar 3.

synthesis cytostatic antiviral profiling thieno-fused 7-deazapurine
ribonucleosides.

tichý m(1), smoleń s(1), tloušt'ová e(1), pohl r(1), oždian t(2), hejtmánková
k(2), lišková b(2), gurská s(2), džubák p(2), hajdúch m(2), hocek m(1)(3).

author information: 
(1)institute organic chemistry biochemistry, czech academy sciences,
gilead sciences & iocb research center , flemingovo nam. 2, cz-16610 prague 6,
czech republic.
(2)institute molecular translational medicine, palacky university and
university hospital olomouc, faculty medicine dentistry , hněvotínská
5, cz-775 15 olomouc, czech republic.
(3)department organic chemistry, faculty science, charles university in
prague , hlavova 8, cz-12843 prague 2, czech republic.

two isomeric series new thieno-fused 7-deazapurine ribonucleosides (derived
from 4-substituted thieno[2',3':4,5]pyrrolo[2,3-d]pyrimidines and
thieno[3',2':4,5]pyrrolo[2,3-d]pyrimidines) synthesized sequence
involving negishi coupling 4,6-dichloropyrimidine iodothiophenes,
nucleophilic azidation, cyclization tetrazolopyrimidines, followed by
glycosylation cross-couplings nucleophilic substitutions position 4.
most nucleosides (from isomeric series) exerted low micromolar or
submicromolar vitro cytostatic activities broad panel cancer 
leukemia cell lines antiviral activity hcv. active were
the 6-methoxy, 6-methylsulfanyl, 6-methyl derivatives, highly
active cancer cells less toxic nontoxic fibroblasts.

doi: 10.1021/acs.jmedchem.6b01766 
pmid: 28221790  [indexed medline]

